Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8211613 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 17 Pages |
Abstract
We observed no significant differences in survival according to receipt of WBRT in favorable-prognosis NSCLC patients. This study further supports the approach of SRS alone in the majority of patients with limited brain metastases.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Thomas M. MD, Karla V. PhD, Paul D. MD, Erin L. MS, Kurt MD, Elana PhD, Jane H. PhD, S. Keith MS, Xiomara W. BS, Yolanda I. MD, Fred G. MD, Richard MD, Jesse G. BS, Stuart H. MD, Caroline MD, Cynthia MD, Volker W. MD, Bruce E. MD, Anthony L. MD,